OPEN Health and Pharmerit Combine the Best of Both Worlds
Discover where the next step in your career could take you.
Why Pharmerit and OPEN Health?
Together, we offer a truly comprehensive suite of services to identify and address evidence gaps and deliver world class communications across a wide range of media. Combined with our broad scope of therapeutic expertise, we produce results and solutions that are of the highest quality.
What We Do
Our multidisciplinary teams work across 4 Centers of Excellence to communicate a product’s value.
Latest News and Views
Disruptive Listening to Better Engage Patients in Research
Highlights from the Patients as Partners Europe Virtual Conference
Patient Engagement in Health Technology Assessment – Practices and Principles for Europe & the United States – Report Now Available
Patient Engagement in Health Technology Assessment – Report Now Available
The Proper Order of Things is Often A Mystery: A Novel Approach to Selecting Treatment Sequences
Watch the recording of the ISPOR webinar
Solving pharma’s biggest challenges
People are at the heart of our business. Without our incredibly talented people, we couldn’t offer our clients the world-class service they have come to expect.
We know how important it is to support, develop, reward and encourage our team. And that’s just part of what makes Pharmerit – an OPEN Health Company a great place to work.
Latest News
Potential Public Health Impact of A Neisseria Meningitidis A, B, C, W, And Y Pentavalent Vaccine In The United States
Potential Public Health Impact of A Neisseria Meningitidis
Cost-Effectiveness for KTE-X19 CAR T Therapy for Adult Patients with Relapsed/Refractory Mantle Cell Lymphoma in the United States
Cost-Effectiveness for KTE-X19 CAR T Therapy for Adult
Comparative Efficacy, Safety and Durability of Dolutegravir Relative to Common Core Agents in Treatment-Naïve Patients Infected with HIV-1: An Update On A Systematic Review and Network Meta-Analysis
Comparative Efficacy, Safety and Durability of Dolutegravir Relative
